International Workshop on HIV & Aging 2021

The International Workshop on HIV & Aging was held virtually on 23-24 September 2021. The mission of this Workshop was to provide a unique and much-needed platform to integrate the disparate fields of geriatrics, internal medicine, HIV biology, pharmacology, psychology, and numerous medical subspecialties in an interactive and focused setting that presents and discusses the latest biological knowledge and strategies that may improve the future of persons aging with HIV. With the dramatically extended life expectancy of those living with HIV due to effective antiretroviral therapy (ART), this mission becomes more vital with each passing year. 

People receiving ART rarely die from AIDS, but in comparison to similar HIV-negative populations, they may experience an excess of morbidity and mortality including a relatively early onset of aging complications such as neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. It is a very high priority to understand the interaction between age and HIV infection that accounts for this clinical picture. To this end, the Workshop had an intimate size and multidisciplinary program intended promote professional interactions, which have led to many long-lasting and productive collaborations. The Workshop also prioritized opportunities for trainees and junior investigators to present their research, network, and learn from experts in the field.

This year, we are excited that the Workshop included a highly diverse team of basic and clinical scientists, clinicians, trainees, and community members. The program delved into basic science (for example, immunosenescence and inflammation in aging) and clinical challenges (for example, neurological and mental health impairments, remote delivery of health care, and approaches to frailty). Hot topics included a variety of speaker and panels covering the effects and clinical consequences of COVID-19 infection on aging with HIV. Through abstract presentations and organized discussions of the oral and poster presentations, the 12th workshop was stimulating and successful. 

To stay updated on our upcoming programs, make sure you are signed up for our newsletter.

Practical Information 

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in research and clinical management of people aging with HIV.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Goda Adomonis at goda.adomonis@amededu.com or call +31 6 23711504.

By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgment during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgment on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag

*Subject to the support level

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts. 

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Dorcas Baker, RN, BSN, ACRN, MA, Johns Hopkins University School of Nursing, MidAtlantic AIDS Education and Training Center (AETC), United States
• Bruce Brew, MD, St Vincent's Hospital, Australia
• Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
• Simon Collins, HIV i-Base, United Kingdom
• Daniel Duprez, MD, University of Minnesota (Cardiology), United States
• Meredith  Greene, MD, UCSF, United States
• Giovanni Guaraldi, MD, Policlinico Modena, Italy
• Marcia McDonnell  Holstad, PhD, Emory University, United States
• Jordan  Lake, MD, MSc, UTHealth, United States
• Alan Landay, PhD, Rush University Medical Center, United States
• Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
• Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona , Spain
• Kelly O'Brien, PhD, BScPT, BSc, University of Toronto, Department of Physical Therapy, Canada
• Brendan Payne, PhD, Newcastle University, United Kingdom
• Molly Perkins, PhD, Emory University School of Medicine, United States
• Matilde Sanchez Conde, MD, PhD, Hospital Ramón y Cajal, Spain
• Eugenia Siegler, MD, Weill Cornell Medicine, United States
• Jeff Taylor, HIV + Aging Research Project - Palm Springs, United States
• Phyllis Tien, MD, MSc, University of California, San Francisco, United States
• Cara Wilson, MD, University of Colorado, United States

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

• Andrew Clark, MD, ViiV Healthcare, United Kingdom
• Richard Haubrich, MD, Gilead Sciences, United States
• Christian Marsolais, PhD, Theratechnologies, Canada

The International Workshop on HIV & Aging 2021, Utrecht (Livestream), Netherlands, 23/09/2021-24/09/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”